Sponsor Pipeline

Sizhen Wang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07230301 Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal… Pancreatic Cancer Metastatic Not Yet Recruiting
Disease Areas
Get alerts when Sizhen Wang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free